A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma

Title
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma
Authors
Keywords
Toxicity, Small cell lung cancer, Cancer treatment, Chemotherapy, Mitochondria, Nausea, Cancer chemotherapy, Computed axial tomography
Journal
PLoS One
Volume 11, Issue 10, Pages e0164244
Publisher
Public Library of Science (PLoS)
Online
2016-10-13
DOI
10.1371/journal.pone.0164244

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started